94 related articles for article (PubMed ID: 18342665)
1. Biodegradable drug-eluting stents: promises and pitfalls.
Di Mario C; Ferrante G
Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665
[No Abstract] [Full Text] [Related]
2. Very late stent thrombosis with newer drug-eluting stents: no longer an issue?
de la Torre Hernández JM; Windecker S
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):595-8. PubMed ID: 22627073
[No Abstract] [Full Text] [Related]
3. Biodegradable coating for drug-eluting stents--more than a facelift?
Niemelä KO
Eur Heart J; 2008 Aug; 29(16):1930-1. PubMed ID: 18586664
[No Abstract] [Full Text] [Related]
4. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
Räber L; Magro M; Stefanini GG; Kalesan B; van Domburg RT; Onuma Y; Wenaweser P; Daemen J; Meier B; Jüni P; Serruys PW; Windecker S
Circulation; 2012 Mar; 125(9):1110-21. PubMed ID: 22302840
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
[No Abstract] [Full Text] [Related]
6. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents: is new necessarily better?
Waksman R
Lancet; 2008 Sep; 372(9644):1126-8. PubMed ID: 18765163
[No Abstract] [Full Text] [Related]
8. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all.
Abu Sharar H; Katus HA; Bekeredjian R
Int J Cardiol; 2014 Dec; 177(3):1067-8. PubMed ID: 25465842
[No Abstract] [Full Text] [Related]
10. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
12. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
[TBL] [Abstract][Full Text] [Related]
13. Everolimus versus sirolimus-eluting stents for the treatment of sirolimus-eluting stent restenosis.
Yan RQ; Gao LJ; Chen JL
Int J Cardiol; 2013 May; 165(3):568-9. PubMed ID: 23040998
[No Abstract] [Full Text] [Related]
14. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial.
Onuma Y; Serruys PW; Ormiston JA; Regar E; Webster M; Thuesen L; Dudek D; Veldhof S; Rapoza R
EuroIntervention; 2010 Sep; 6(4):447-53. PubMed ID: 20884431
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
Stefanini GG; Byrne RA; Serruys PW; de Waha A; Meier B; Massberg S; Jüni P; Schömig A; Windecker S; Kastrati A
Eur Heart J; 2012 May; 33(10):1214-22. PubMed ID: 22447805
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
Kastrati A; Mehilli J; Pache J; Kaiser C; Valgimigli M; Kelbaek H; Menichelli M; Sabaté M; Suttorp MJ; Baumgart D; Seyfarth M; Pfisterer ME; Schömig A
N Engl J Med; 2007 Mar; 356(10):1030-9. PubMed ID: 17296823
[TBL] [Abstract][Full Text] [Related]
17. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace.
Spagnoli V; Veugeois A; Caussin C; Amabile N
Eur Heart J; 2013 Aug; 34(31):2428. PubMed ID: 23821398
[No Abstract] [Full Text] [Related]
18. Stent thrombosis in randomized clinical trials of drug-eluting stents.
Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
[TBL] [Abstract][Full Text] [Related]
19. What is the optimal time to estimate the final vascular response to a drug-eluting stent by optimal coherence tomography?
Koh YS; Baek SH
Circ J; 2014; 78(10):2376-7. PubMed ID: 25187066
[No Abstract] [Full Text] [Related]
20. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
Byrne RA; Kastrati A; Massberg S; Wieczorek A; Laugwitz KL; Hadamitzky M; Schulz S; Pache J; Fusaro M; Hausleiter J; Schömig A; Mehilli J;
J Am Coll Cardiol; 2011 Sep; 58(13):1325-31. PubMed ID: 21920260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
